Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Connective tissue diseases and the liver.

Wael I Youssef1, Anthony S Tavill

  • 1Division of Gastroenterology and The Robert Schwartz Center for Metabolism and Nutrition at MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio 44109, USA.

Journal of Clinical Gastroenterology
|September 28, 2002
PubMed
Summary

Connective tissue diseases can affect the liver, often presenting as common abnormalities like fatty liver. Distinguishing primary liver disease from autoimmune conditions is crucial for proper patient management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Unusual Suspect: A Case of Non-occlusive Mesenteric Ischemia in a Patient With Cirrhosis.

Gastroenterology research·2016
Same author

In Reply: Wilson disease.

Cleveland Clinic journal of medicine·2016
Same author

A tale of two sisters with liver disease.

Cleveland Clinic journal of medicine·2016
Same author

Concomitant presentation of collagenous sprue and HFE hemochromatosis.

Journal of Crohn's & colitis·2011
Same author

Acute liver failure: an uncommon complication of commonly used medication.

American journal of therapeutics·2011
Same author

Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Hepatology (Baltimore, Md.)·2011

Area of Science:

  • Hepatology
  • Rheumatology
  • Autoimmunology

Background:

  • Connective tissue diseases (CTDs) like SLE and rheumatoid arthritis are systemic autoimmune disorders.
  • Liver involvement in CTDs is documented but often considered rare, with advanced disease being uncommon.
  • Commonly, liver issues in CTD patients are attributed to hepatotoxic drugs or viral hepatitis.

Purpose of the Study:

  • To review current data on liver involvement in patients with connective tissue diseases.
  • To explore the diagnostic dilemma between primary liver disease and CTD-manifested liver disease.
  • To highlight various hepatic abnormalities associated with CTDs.

Main Methods:

  • Review of published data on liver involvement in connective tissue diseases.

Related Experiment Videos

  • Analysis of clinical and histopathologic features differentiating autoimmune hepatitis and SLE-associated hepatitis.
  • Examination of common and less frequent hepatic abnormalities in CTD patients.

    • Main Results:

    • Hepatic steatosis and abnormal liver function tests are the most frequent hepatic abnormalities in CTDs.
    • Less common findings include nodular regenerative hyperplasia, portal hypertension, and primary biliary cirrhosis features.
    • Vascular liver disorders like Budd-Chiari syndrome are also described in CTD patients.

    Conclusions:

    • Liver involvement in CTDs, though often subclinical, is more common than previously thought.
    • Differentiating primary liver disease from CTD-related liver manifestations is critical for treatment and prognosis.
    • Histologic assessment is vital for identifying diverse subclinical liver diseases in CTD patients.